Trial Profile
A multicentre, interventional, parallel group, randomised, open-label, exploratory study to assess the earlier introduction of Ivabradine in the Management of Systolic Dysfunction Heart Failure. The QUALIVA study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2019
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Bisoprolol; Carvedilol
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms QUALIVA
- 07 Feb 2019 Status changed from completed to discontinued.
- 30 Jun 2016 Status changed from recruiting to completed.
- 09 Oct 2015 New trial record